Amalgamated Bank Pulse Biosciences, Inc. Transaction History
Amalgamated Bank
- $12.6 Billion
- Q2 2025
A detailed history of Amalgamated Bank transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 632 shares of PLSE stock, worth $9,296. This represents 0.0% of its overall portfolio holdings.
Number of Shares
632
Previous 632
-0.0%
Holding current value
$9,296
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PLSE
# of Institutions
89Shares Held
5.59MCall Options Held
76.1KPut Options Held
60.8K-
Black Rock Inc. New York, NY1.15MShares$16.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA843KShares$12.4 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC778KShares$11.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA499KShares$7.35 Million0.0% of portfolio
-
State Street Corp Boston, MA419KShares$6.17 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $546M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...